Martin Reck, Head of Department at LungenClinic Grosshansdorf, shared on LinkedIn, quoting to Department of Translational Genomics:
“Don’t miss this outstanding conference! A fantastic opportunity to interact and get in touch with research behind the incredible development in lung cancer!”
Department of Translational Genomics posted:
“Save the Date: 4th Cologne Conference on Lung Cancer – June 24-25, 2027.
After the great success of the 3rd CCLC in 2025, we are excited to share that the Cologne Conference on Lung Cancer is coming back! The meeting will take place at the Maritim Hotel in Cologne and bring together leading voices in translational lung cancer research.
Topics include:
- Tumor Evolution,
- The Future Therapeutic Toolbox,
- Epigenetic Plasticity and Heterogeneity,
- Predicting Resistance,
- Lung Cancer Physiology.
Confirmed speakers so far (more to be announced):
Max Diehn (Stanford, USA), Julie George (Cologne, DE), John Heymach (TX, USA), Hongbin Ji (Hangzhou, CN), Mark Krasnow (Stanford, USA), Leanne Li (London, UK), Nicky McGranahan (London, UK), Trudy Oliver (NC, USA), Matthew Oser (Boston, USA), Tej Pandya (London, UK), Thales Papagiannakopoulos (CA, USA), Luis Paz-Ares (Madrid, ES), Katerina Politi (CT, USA), Martin Reck (Großhansdorf, DE), Charles Rudin (NYC, USA), Mallika Singh (CA, USA), Tuomas Tammela (NYC, USA), Yuri Tolkach (Cologne, DE), Silvia von Karstedt (Cologne, DE), Kwong-Kwok Wong (NYC, USA), Caicun Zhou (Shanghai, CN).
With this outstanding international lineup and a strong focus on interactive discussion, this promises to be a fantastic meeting.
Organized by Julien Sage, Reinhard Buettner, Univ.-Prof. Dr., Roman Thomas and Jürgen Wolf.
Looking forward to seeing many of you in Cologne next June!”
You can read more about the conference on OncoDaily:
